TYNDALL CAPITAL PARTNERS L P sold 0.2% of their position (1.25K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/13/2019ACC: 0000905718-19-000775
10% Owner
Since Jun 2019
-1.25K
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.25K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1.25K
Price / share
$2.75
Trade value
$3.43K
% of position
0.2%
9/11/2019
796.69K→795.45K
Total
Net shares
−1.25K
Net value
-$3.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/11/2019 | S · Sale | −1.25K | $2.75 | $3.43K | 0.2% | 796.69K | 795.45K |
| Total | −1.25K | -$3.43K | ||||||
Derivative Transactions0
No derivative transactions reported